Skip to main content
. 2010 Jul 28;2010:402750. doi: 10.1155/2010/402750

Figure 3.

Figure 3

(a) Evolution of inverse of creatinine (1/SeCr) over time in the randomization population (MMF group versus control group). (b) Evolution of inverse of creatinine (1/SeCr) over time in the on-treatment population (group I versus group II). The vertical, dotted line separates initial study phase and follow up phase.